Ad is loading...
CELC
Price
$12.78
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
118 days until earnings call
PLRX
Price
$12.85
Change
+$0.12 (+0.94%)
Updated
Nov 21 closing price
102 days until earnings call
Ad is loading...

CELC vs PLRX

Header iconCELC vs PLRX Comparison
Open Charts CELC vs PLRXBanner chart's image
Celcuity
Price$12.78
Change-$0.00 (-0.00%)
Volume$261.76K
CapitalizationN/A
Pliant Therapeutics
Price$12.85
Change+$0.12 (+0.94%)
Volume$691.73K
CapitalizationN/A
CELC vs PLRX Comparison Chart
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CELC vs. PLRX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a StrongSell and PLRX is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (CELC: $12.73 vs. PLRX: $12.85)
Brand notoriety: CELC and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 78% vs. PLRX: 151%
Market capitalization -- CELC: $472.66M vs. PLRX: $781.97M
CELC [@Biotechnology] is valued at $472.66M. PLRX’s [@Biotechnology] market capitalization is $781.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 5 TA indicator(s) are bullish while PLRX’s TA Score has 5 bullish TA indicator(s).

  • CELC’s TA Score: 5 bullish, 5 bearish.
  • PLRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CELC and PLRX are a good buy in the short-term.

Price Growth

CELC (@Biotechnology) experienced а -9.78% price change this week, while PLRX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

CELC is expected to report earnings on Mar 20, 2025.

PLRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($782M) has a higher market cap than CELC($473M). CELC YTD gains are higher at: -12.629 vs. PLRX (-29.045). CELC has higher annual earnings (EBITDA): -85.45M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. CELC (264M). PLRX has less debt than CELC: PLRX (60.2M) vs CELC (97.2M). CELC (0) and PLRX (0) have equivalent revenues.
CELCPLRXCELC / PLRX
Capitalization473M782M60%
EBITDA-85.45M-197.04M43%
Gain YTD-12.629-29.04543%
P/E RatioN/AN/A-
Revenue00-
Total Cash264M405M65%
Total Debt97.2M60.2M161%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCPLRX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
CELC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIPPX11.850.21
+1.80%
Principal MidCap Growth R4
UBVLX92.611.34
+1.47%
Undiscovered Managers Behavioral Val L
UNWPX1.530.01
+0.66%
US Global Investors World Prec Mnral
TCSHX14.530.06
+0.41%
Transamerica Multi-Asset Income C
SIDVX10.190.01
+0.10%
Hartford Schroders Intl Multi-Cp Val A

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with PLRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-0.39%
PLRX - CELC
42%
Loosely correlated
+0.94%
INZY - CELC
41%
Loosely correlated
-3.58%
SNDX - CELC
40%
Loosely correlated
-2.19%
ABOS - CELC
39%
Loosely correlated
-2.53%
AVTX - CELC
39%
Loosely correlated
-11.47%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+0.94%
NTLA - PLRX
51%
Loosely correlated
+5.18%
RCKT - PLRX
51%
Loosely correlated
-1.92%
BEAM - PLRX
50%
Loosely correlated
-3.72%
ABSI - PLRX
49%
Loosely correlated
-4.85%
PRME - PLRX
48%
Loosely correlated
-0.67%
More